0026-895X/03/6403-550-556$20.00
Mol Pharmacol 64:550-556, 2003
ACCELERATED COMMUNICATION
Aspartate Aminotransferase Generates Proagonists of the Aryl Hydrocarbon Receptor
Mark A. Bittinger,
Linh P. Nguyen, and
Christopher A. Bradfield
McArdle Laboratory for Cancer Research, University of Wisconsin Medical
School, Madison, Wisconsin
The aryl hydrocarbon receptor (AHR) binds planar aromatic compounds and
up-regulates the transcription of a battery of xenobiotic-metabolizing
enzymes. To identify proteins involved in the biosynthesis of endogenous AHR
ligands, we screened extracts of various mouse tissues for AHR signaling
activity. We found heart extract to activate AHR and identified the active
component to be the enzyme aspartate aminotransferase (EC 2.6.1.1). We
demonstrate that this transaminase can activate AHR signaling by converting
L-tryptophan to indole-3-pyruvate. In turn, indole-3-pyruvate
spontaneously reacts in aqueous solution to form a large number of compounds
that act as agonists of AHR. Tyrosine and the serotonin-precursor
5-hydroxytryptophan also activate AHR signaling in combination with aspartate
aminotransferase, suggesting that 4-hydroxyphenylpyruvate and
5-hydroxyindolepyruvate also act as proagonists of AHR. This study
demonstrates that the known tryptophan metabolic-intermediate
indole-3-pyruvate is a proagonist of AHR that reacts in aqueous solution to
form a variety of AHR agonists.
Received May 9, 2003;
accepted May 30, 2003
Address correspondence to: Christopher A. Bradfield, Ph.D., McArdle
Laboratory for Cancer Research, 1400 University Avenue, Madison, WI 53706.
E-mail:
bradfield{at}oncology.wisc.edu
This article has been cited by other articles:

|
 |

|
 |
 
I. Teneng, V. Stribinskis, and K. S. Ramos
Context-specific regulation of LINE-1
Genes Cells,
October 1, 2007;
12(10):
1101 - 1110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. J. McMillan and C. A. Bradfield
The Aryl Hydrocarbon Receptor sans Xenobiotics: Endogenous Function in Genetic Model Systems
Mol. Pharmacol.,
September 1, 2007;
72(3):
487 - 498.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Okey
An Aryl Hydrocarbon Receptor Odyssey to the Shores of Toxicology: The Deichmann Lecture, International Congress of Toxicology-XI
Toxicol. Sci.,
July 1, 2007;
98(1):
5 - 38.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. G. Woods, J. P. Vanden Heuvel, and I. Rusyn
Genomic Profiling in Nuclear Receptor-Mediated Toxicity
Toxicol Pathol,
June 1, 2007;
35(4):
474 - 494.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Hu, C. Sorrentino, M. S. Denison, K. Kolaja, and M. R. Fielden
Induction of Cyp1a1 Is a Nonspecific Biomarker of Aryl Hydrocarbon Receptor Activation: Results of Large Scale Screening of Pharmaceuticals and Toxicants in Vivo and in Vitro
Mol. Pharmacol.,
June 1, 2007;
71(6):
1475 - 1486.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Diani-Moore, E. Labitzke, R. Brown, A. Garvin, L. Wong, and A. B. Rifkind
Sunlight Generates Multiple Tryptophan Photoproducts Eliciting High Efficacy CYP1A Induction in Chick Hepatocytes and In Vivo
Toxicol. Sci.,
March 1, 2006;
90(1):
96 - 110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Mulero-Navarro, E. Pozo-Guisado, P. A. Perez-Mancera, A. Alvarez-Barrientos, I. Catalina-Fernandez, E. Hernandez-Nieto, J. Saenz-Santamaria, N. Martinez, J. M. Rojas, I. Sanchez-Garcia, et al.
Immortalized Mouse Mammary Fibroblasts Lacking Dioxin Receptor Have Impaired Tumorigenicity in a Subcutaneous Mouse Xenograft Model
J. Biol. Chem.,
August 5, 2005;
280(31):
28731 - 28741.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics